Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study.
Adnan GündoğduMehmet UluşahinArif Burak ÇekiçSeher Nazlı KazazAli GünerPublished in: Turkish journal of surgery (2024)
The presented study underscores the relevance of molecular subtypes in determining the response to neoadjuvant chemotherapy in breast cancer patients. Particularly HER2-positive and triple-negative subtypes may demonstrate more favorable response rates.